Close menu

SURE

Sunderland Repository records the research produced by the University of Sunderland including practice-based research and theses.

New potent and selective tankyrase inhibitors for the treatment of disease or conditions associated with Wnt signalling e.g. colon cancer, prostate cancer, idiopathic pulmonary fibrosis, chronic obstructive pulmonary disease and type-1/type-2 diabetes.

This is the latest version of this item.

Nathubhai, Amit, Threadgill, M D (2016) New potent and selective tankyrase inhibitors for the treatment of disease or conditions associated with Wnt signalling e.g. colon cancer, prostate cancer, idiopathic pulmonary fibrosis, chronic obstructive pulmonary disease and type-1/type-2 diabetes. WO2017-GB52624.

Item Type: Patents
Full text not available from this repository.

More Information

Depositing User: Amit Nathubhai

Identifiers

Item ID: 9804
Identification Number: WO2017-GB52624
URI: http://sure.sunderland.ac.uk/id/eprint/9804
Official URL: https://worldwide.espacenet.com/publicationDetails...

Users with ORCIDS

Catalogue record

Date Deposited: 10 Aug 2018 13:52
Last Modified: 18 Dec 2019 16:07

Contributors

Author: Amit Nathubhai
Author: M.D. Threadgill

University Divisions

Faculty of Health Sciences and Wellbeing
Faculty of Health Sciences and Wellbeing > School of Pharmacy and Pharmaceutical Sciences

Subjects

Sciences > Chemistry

Actions (login required)

View Item (Repository Staff Only) View Item (Repository Staff Only)

Available Versions of this Item